Phase 1 Study of CEP-37250/KHK2804 in Subjects With Advanced Solid Tumors

NCT01447732 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

71

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumour
Adenocarcinoma of the Colorectal
Adenocarcinoma of the Pancreas

Interventions

DRUG: CEP-37250/KHK2804

Sponsor

Kyowa Kirin Co., Ltd.

Collaborators

[object Object]
[object Object]